Predicting gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs)
US9988684B2 · kind B2 · utility
0Cited by
0References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 3, 2013 |
| Grant date | Jun 5, 2018 |
| Priority date | — |
| Expiry date | Sep 3, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/57438
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Described are embodiments related to gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) biomarkers and agents, systems, and kits for detecting the same, and associated GEP-NEN diagnostic, prognostic, and predictive methods and uses thereof, such as detection, prediction, staging, profiling, classification, and monitoring treatment efficacy and other outcomes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.